The connection between sleep and heart disease
This audio clip is from episode #48 with Matthew Walker, Ph.D., on sleep – Part II of III: Heart disease, cancer,…
Cumulative effects of LDL-C reduction in mitigating cardiovascular risk
Atherosclerotic cardiovascular disease (ASCVD) is currently the leading cause of death in the U.S. One of the most effective ways to reduce risk of ASCVD mortality is reduction of apoB particle number, typically estimated by LDL cholesterol (LDL-C) concentrations.
Lp(a) and CVD risk & clinical tests to measure Lp(a)
This video clip is from episode #210 – Lp(a) and its impact on heart disease with Benoît Arsenault, Ph.D., originally…
Can cocoa help prevent cardiovascular death?
A recent study explored whether supplementation with the beneficial compounds in cocoa could have a clinically-relevant effect on ASCVD.
Peter’s approach to managing patients with high Lp(a)
This video is a clip from episode #210 – Lp(a) and its impact on heart disease with Benoît Arsenault, Ph.D.,…
#210 – Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.
“I think we should advise people to measure Lp(a); that would be a gigantic step.” —Benoît Arsenault
For triglycerides, “normal” may not be “optimal”
How do triglyceride levels relate to cardiovascular risk?
Intro to lipids & lipoproteins: why there is no ‘bad’ or ‘good’ cholesterol
I recently posted on Twitter about my frustration with the way the press writes about “good” and “bad” cholesterol, and…
Peter on the four horsemen of chronic disease
This audio clip is from AMA #14: What lab tests can (and cannot) inform us about our overall objective of…
#203 – AMA #34: What Causes Heart Disease?
“Not everybody dies from atherosclerosis, but… everybody dies with it.” — Peter Attia